Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
argenx SE - American Depositary Shares
(NQ:
ARGX
)
780.25
-7.70 (-0.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about argenx SE - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
November 20, 2024
From
argenx SE
Via
GlobeNewswire
(ARGX) - Analyzing argenx's Short Interest
↗
November 14, 2024
Via
Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
↗
November 12, 2024
Via
Benzinga
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
November 11, 2024
From
Zai Lab Limited
Via
Business Wire
Peering Into argenx's Recent Short Interest
↗
November 06, 2024
Via
Benzinga
The Latest Analyst Ratings For argenx
↗
October 17, 2024
Via
Benzinga
Peeling Back The Layers: Exploring argenx Through Analyst Insights
↗
September 26, 2024
Via
Benzinga
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
November 11, 2024
From
argenx SE
Via
GlobeNewswire
This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
↗
November 05, 2024
Via
Benzinga
argenx to Participate at Upcoming Investor Conferences
November 05, 2024
From
argenx SE
Via
GlobeNewswire
Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'
↗
November 01, 2024
Argenx SE ADR shares jumped after impressive earnings. Analysts raised price targets and noted strong pipeline and global expansion.
Via
Benzinga
This Atlassian Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
↗
November 01, 2024
Via
Benzinga
What 25 Analyst Ratings Have To Say About argenx
↗
August 23, 2024
Via
Benzinga
The Analyst Verdict: argenx In The Eyes Of 27 Experts
↗
July 29, 2024
Via
Benzinga
This Huntington Ingalls Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
↗
November 01, 2024
Via
Benzinga
argenx Reports Third Quarter 2024 Financial Results and Provides Business Update
October 31, 2024
From
argenx SE
Via
GlobeNewswire
argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
October 24, 2024
From
argenx SE
Via
GlobeNewswire
argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions
October 15, 2024
From
argenx SE
Via
GlobeNewswire
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
↗
October 01, 2024
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds.
Via
Talk Markets
Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases
↗
September 25, 2024
Amgen tested its drug, Uplizna, in generalized myasthenia gravis, a market where Argenx's Vyvgart leads.
Via
Investor's Business Daily
Snowflake, Hawaiian Electric Industries And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
September 24, 2024
Via
Benzinga
argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy
September 19, 2024
From
argenx SE
Via
GlobeNewswire
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
↗
August 29, 2024
Johnson & Johnson has submitted a Biologics License Application (BLA) to the FDA for nipocalimab, seeking its first global approval for generalized myasthenia gravis (gMG). This submission follows...
Via
Benzinga
argenx to Present at Upcoming Investor Conferences
August 28, 2024
From
argenx SE
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 12, 2024
Via
Benzinga
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
↗
August 06, 2024
Via
Benzinga
Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
↗
July 29, 2024
Via
Benzinga
argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update
July 25, 2024
From
argenx SE
Via
GlobeNewswire
argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024
July 18, 2024
From
argenx SE
Via
GlobeNewswire
argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
July 16, 2024
From
argenx SE
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
